The increased expression of CD14+ CD16+ and CD14low CD16++ monocyte subsets in patients with active RA may suggest the progression of the disease [10, 46, 47], but may also reflect the activation of the monocyte population. This evidence concerns the gene CD14 and rheumatoid arthritis.